{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:29:20Z","timestamp":1788150560811,"version":"build-2803163510"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s40744-018-0126-2","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T05:24:21Z","timestamp":1537853061000},"page":"499-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Clinical and Immunological Features of Anti-centromere Antibody-Positive Primary Sj\u00f6gren\u2019s Syndrome"],"prefix":"10.1007","volume":"5","author":[{"given":"Masako","family":"Tsukamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"key":"126_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","volume":"74","author":"X Mariette","year":"2015","unstructured":"Mariette X, Seror R, Quartuccio L, et al. Efficacy and safety of belimumab in primary Sj\u00f6gren\u2019s syndrome: results of the BELISS open-label phase II study. Ann Rheum Dis. 2015;74:526\u201331.","journal-title":"Ann Rheum Dis"},{"key":"126_CR2","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.autrev.2012.08.001","volume":"12","author":"D Guellec","year":"2013","unstructured":"Guellec D, Cornec D, Jousse-Joulin S, et al. Diagnostic value of labial minor salivary gland biopsy for Sj\u00f6gren\u2019s syndrome: a systematic review. Autoimmun Rev. 2013;12:416\u201320.","journal-title":"Autoimmun Rev"},{"key":"126_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1586\/1744666X.2014.900441","volume":"10","author":"D Zhou","year":"2014","unstructured":"Zhou D, McNamara NA. Macrophages: important players in primary Sj\u00f6gren\u2019s syndrome? Expert Rev Clin Immunol. 2014;10:513\u201320.","journal-title":"Expert Rev Clin Immunol"},{"key":"126_CR4","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/acr.22859","volume":"68","author":"AN Baer","year":"2016","unstructured":"Baer AN, Medrano L, McAdams-DeMarco M, Gniadek TJ. Association of anticentromere antibodies with more severe exocrine glandular dysfunction in Sj\u00f6gren\u2019s syndrome: analysis of the Sj\u00f6gren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2016;68:1554\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"126_CR5","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/art.30381","volume":"63","author":"TE Daniels","year":"2011","unstructured":"Daniels TE, Cox D, Shiboski CH, et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sj\u00f6gren\u2019s syndrome among 1,726 registry participants. Arthritis Rheum. 2011;63:2021\u201330.","journal-title":"Arthritis Rheum"},{"key":"126_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76:9\u201316.","journal-title":"Ann Rheum Dis"},{"key":"126_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","volume":"75","author":"R Seror","year":"2016","unstructured":"Seror R, Bootsma H, Saraux A, et al. Defining disease activity states and clinically meaningful improvement in primary Sj\u00f6gren\u2019s syndrome with EULAR primary Sj\u00f6gren\u2019s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis. 2016;75:382\u20139.","journal-title":"Ann Rheum Dis"},{"key":"126_CR8","first-page":"2238","volume":"28","author":"K Katano","year":"2001","unstructured":"Katano K, Kawano M, Koni I, Sugai S, Muro Y. Clinical and laboratory features of anticentromere antibody positive primary Sj\u00f6gren\u2019s syndrome. J Rheumatol. 2001;28:2238\u201344.","journal-title":"J Rheumatol"},{"key":"126_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/1756-185X.12684","volume":"18","author":"KE Lee","year":"2015","unstructured":"Lee KE, Kang JH, Lee JW, et al. Anti-centromere antibody-positive Sj\u00f6gren\u2019s syndrome: a distinct clinical subgroup? Int J Rheum Dis. 2015;18:776\u201382.","journal-title":"Int J Rheum Dis"},{"key":"126_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.autrev.2010.09.025","volume":"10","author":"MJ Fritzler","year":"2011","unstructured":"Fritzler MJ, Rattner JB, Luft LM, et al. Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F. Autoimmun Rev. 2011;10:194\u2013200.","journal-title":"Autoimmun Rev"},{"key":"126_CR11","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-018-0126-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-018-0126-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-018-0126-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T23:37:29Z","timestamp":1724456249000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-018-0126-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1007\/s40744-018-0126-2","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"assertion":[{"value":"8 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}